Today, pharma companies are under greater economic and regulatory pressure than ever. On the one hand, we are seeing costs of drug development shooting up in the past decade. And on the other hand, we see a lot of new regulatory guidelines in terms of medicine efficacy being implemented at length. These challenges are expected to intensify even further in the coming months as the demand for improved safety data and comparative efficacy studies grows.
Amid this landscape, many pharma companies are looking for innovations and smarter ways of doing business. One of the major trends resulting from high costs is companies outsourcing their clinical research activities to contract research organisations (CROs). These service providers can support pharma companies with a wide range of services like preclinical evaluations, study design, clinical trial planning and management, independent safety data monitoring, bio-statistical analysts and many more.
Amid such trends making a wave in the pharma sector, organisations must equip themselves with the latest and most effective technologies. In order to assist such companies in shoring up their capabilities, we have compiled this issue of Pharma Tech Outlook Europe. In this edition, we have listed the top 10 CROs in Europe to highlight the ones that can help you escalate your chances of success. Equipped with innovative technological capabilities, these enlisted service providers are transforming the pharma landscape at the cloverleaf of various disruptive technologies. Besides, the magazine comprises insights from subject-matter experts and CXOs on the latest industry trends, best practices, recent innovations, and highlights their expertise. We hope this issue of Pharma Tech Outlook Europe helps you build the partnership you and your organisation need to foster an environment driven by robust and efficient technology.
We present to you Pharma Tech Outlook Europe’s “Top 10 CROs in Europe – 2021.”